madman
Super Moderator
Abstract
The aim of this systematic review and meta‐analysis was to evaluate the effect of vitamin D supplementation on total testosterone (TT) and sex hormone‐binding globulin (SHBG) in men. We searched PubMed, Scopus and Web of Science for randomized, controlled trials of vitamin D supplementation in men ≥18 years old up to September 2018, without language restrictions. Meta‐analysis was based on a random effects model. The systematic review was registered as CRD42018094498. We identified 3,402 articles, of which eight studies with 10 effect sizes met the inclusion criteria. Vitamin D daily dose equivalents ranged from 600 to 4,000 per day to 60,000 IU per week; duration was 6 weeks to 36 months. In general, vitamin D supplementation had no significant effect on TT (MD = 0.20, 95% CI: −0.20, 0.60, p = 0.336) and SHBG (MD = 1.56, 95% CI: −0.85, 3.97, p = 0.204). Subgroup analysis conducted with duration of prescription, type (daily or weekly), dosing frequency and baseline vitamin D and TT concentration showed that vitamin D did not significantly affect TT. The present study did not find any evidence to support beneficial effect of vitamin D supplementation on TT and SHBG in men. Thus, further large‐scale randomised controlled trials are required to evaluate the effects of vitamin D supplementation on androgen in men.
5 | CONCLUSION
This paper presented outcomes that investigated the effect of vitamin D supplementation on androgen levels in men. The main outcome of this study reaffirmed the null effect of vitamin D supplementation on TT and SHBG in men. To solve this problem in the future, we recommend further studies that consider the effect of vitamin D over a longer period in men with hypogonadism and severe vitamin D deficiency.
The aim of this systematic review and meta‐analysis was to evaluate the effect of vitamin D supplementation on total testosterone (TT) and sex hormone‐binding globulin (SHBG) in men. We searched PubMed, Scopus and Web of Science for randomized, controlled trials of vitamin D supplementation in men ≥18 years old up to September 2018, without language restrictions. Meta‐analysis was based on a random effects model. The systematic review was registered as CRD42018094498. We identified 3,402 articles, of which eight studies with 10 effect sizes met the inclusion criteria. Vitamin D daily dose equivalents ranged from 600 to 4,000 per day to 60,000 IU per week; duration was 6 weeks to 36 months. In general, vitamin D supplementation had no significant effect on TT (MD = 0.20, 95% CI: −0.20, 0.60, p = 0.336) and SHBG (MD = 1.56, 95% CI: −0.85, 3.97, p = 0.204). Subgroup analysis conducted with duration of prescription, type (daily or weekly), dosing frequency and baseline vitamin D and TT concentration showed that vitamin D did not significantly affect TT. The present study did not find any evidence to support beneficial effect of vitamin D supplementation on TT and SHBG in men. Thus, further large‐scale randomised controlled trials are required to evaluate the effects of vitamin D supplementation on androgen in men.
5 | CONCLUSION
This paper presented outcomes that investigated the effect of vitamin D supplementation on androgen levels in men. The main outcome of this study reaffirmed the null effect of vitamin D supplementation on TT and SHBG in men. To solve this problem in the future, we recommend further studies that consider the effect of vitamin D over a longer period in men with hypogonadism and severe vitamin D deficiency.
